News Novartis issues a life sciences warning in a 'G-Zero' world Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."
R&D How labs can lead the way in sustainability Through focused strategies and industry collaboration, labs can significantly reduce waste, energy usage, and emissions.
Sales & Marketing The hidden IP problem holding innovators back For organisations active in the US market, the impact of patent marking is financial, not administrative.
R&D The Autumn Budget: What it means for UK life sciences deVere and Inventus comment on the UK Autumn Budget and what it means for life sciences in the country.
News £800m life sciences cluster opens in London In a boost for the UK life sciences sector, a new £800m life sciences hub located at Barts Health NHS Trust in London has been opened today.
News Sofinnova Partners raises €650m for early-stage biotechs European life sciences venture capital company Sofinnova Partners has closed its latest fund, Sofinnova Capital XI, raising €650 million.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.